ArticleInternational journal of ophthalmology2026
Clues to prognosis in anterior ischemic optic neuropathy: an optical coherence tomography angiography study.
Article in International journal of ophthalmology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
aimTo investigate optic nerve vascularization in patients with anterior ischemic optic neuropathy (AION) during the first 3mo after onset, using comprehensive ophthalmic assessments combined with optical coherence tomography (OCT) and optical coherence tomography angiography (OCT-A).
methodsA prospective longitudinal observational study was performed with a 3-month follow-up. Clinical data recorded included age, sex, laterality of ocular involvement, AION subtype, previous history of ischemic events, cardiovascular risk factors such as high blood pressure, dyslipidemia, diabetes mellitus, smoking status, obstructive sleep apnea, and systemic treatments received. Functional, structural, and vascular examinations, including best corrected visual acuity (BCVA), visual field, OCT, and OCT-A, were performed at baseline, 1, and 3mo.
resultsTwenty-two subjects included 12 patients with AION and 10 healthy controls were enrolled. Mean age was 63.75±8.32y in the AION group and 61.80±5.04y in the control group (
conclusionVascular parameters derived from OCT-A can act as predictive markers for medium-term visual and structural outcomes in patients with ischemic optic neuropathy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.